HSBC Holdings
SLDB icon

HSBC Holdings’s Solid Biosciences SLDB Stock Holding History

HSBC Holdings’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
27,804
-11,707
-30% -$88.8K ﹤0.01% 2541
2026
Q1 		$284K Buy
39,511
+17,360
+78% +$112K ﹤0.01% 2469
2025
Q4 		$127K Sell
22,151
-1,441
-6% -$7.81K ﹤0.01% 2765
2025
Q3 		$138K Sell
23,592
-1,787
-7% -$10.4K ﹤0.01% 2558
2025
Q2 		$126K Buy
25,379
+6,311
+33% +$22.3K ﹤0.01% 2803
2025
Q1 		$69.8K Buy
19,068
+91
+0.5% +$390 ﹤0.01% 2862
2024
Q4 		$75.1K Buy
18,977
+2,464
+15% +$13.5K ﹤0.01% 2934
2024
Q3 		$115K Buy
+16,513
New +$134K ﹤0.01% 2775
2022
Q4 		– Sell
-2,700
Closed -$21K – 3184
2022
Q3 		$21K Sell
2,700
-882
-25% -$8.89K ﹤0.01% 2870
2022
Q2 		$34K Hold
3,582
– – ﹤0.01% 3167
2022
Q1 		$64K Hold
3,582
– – ﹤0.01% 3179
2021
Q4 		$94K Buy
3,582
+1,586
+79% +$48.5K ﹤0.01% 3148
2021
Q3 		$72K Buy
+1,996
New +$84.8K ﹤0.01% 2913

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HSBC Holdings's SLDB Position: Q2 2026 in Review

HSBC Holdings reduced its Solid Biosciences (SLDB) stake by 30% in Q2 2026, selling an estimated $88.8K and leaving 27,804 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2541.

HSBC Holdings first reported a position in SLDB in Q3 2021 and has held it in 13 quarters since. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • HSBC Holdings held 27,804 shares of Solid Biosciences worth $285K as of Q2 2026.
  • HSBC Holdings sold 11,707 Solid Biosciences shares in Q2 2026, an estimated $88.8K.
  • Solid Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2541 holding.
  • HSBC Holdings first reported a position in Solid Biosciences in Q3 2021 and has held it in 13 quarters since.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.